His No. 23 76ers jersey eclipsed Ohtani’s previous 48-hour sales record set with the Dodgers in 2023.

Prime Medicine has come out ahead in its patent dispute with fellow gene-editing biotech Beam Therapeutics, after a panel of adjudicators ruled that the company did not violate its agreement with Beam ...

Evasion has always been an iffy defense in Path of Exile 2. Unlike Armor that provides a flat damage reduction, there’s always a chance you may be one-shot by enemies on an Evasion build. To solve ...

is a senior editor and founding member of The Verge who covers gadgets, games, and toys. He spent 15 years editing the likes of CNET, Gizmodo, and Engadget. They tell me no one outside Google has seen ...

Blue Origin and NASA's Jet Propulsion Laboratory are teaming up to design an asteroid-defense spacecraft that will deploy a ...

Long-established in accelerator physics, bent crystals are now being explored as tools to measure the fundamental properties of short-lived charm baryons. Halo extraction The first bent crystal of the ...

Every now and then, a new brand pops up on our radar that we feel compelled to tell you about immediately. This isn’t one of those times, and Beams isn’t a new brand. It is, however, newly available ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. The biotech is pioneering treatments based on base ...

The maker of Jim Beam bourbon whiskey said it plans to pause production at its main distillery in Kentucky starting Jan. 1. Jim Beam, which is owned by a U.S. subsidiary of Japan's Suntory Holdings, ...

Multnomah County commissioners were less than dazzled by the performance of the county’s drug deflection center during its first year of operation, which ended Aug. 31. At a briefing Thursday, ...